Survivors of non-small cell lung cancer are at risk for both second primary lung cancers as well as non-lung secondary ...

A recent study has analyzed the relationship between different air pollutants and the main subtypes of lung cancer.

Lung cancer cases are rising among non-smokers. Here's why the proportion is increasing, key causes, early signs, diagnosis, ...

A 25-year study led by the Barcelona Institute for Global Health finds that PM2.5 increases the risk of all lung cancer subtypes, while several gaseous pollutants are associated with non-small-cell ...

Despite a significant 48.8% objective response rate and breakthrough therapy status, this regulatory shift reverses years of ...

A study led by the Barcelona Institute for Global Health (ISGlobal), a centre supported by “la Caixa” Foundation, in collaboration with the American Cancer Society (ACS), analysed the relationship ...

Then you have the fact that clinical trials often underrepresent minorities. This can lead to skewed AI models, with 80 ...

Robert Brown, 81, says the trial has been like a "light at the end of the tunnel." ...

Anktiva, also known as nogapendekin alfa inbakicept, is a new cancer therapy that boosts the immune system to target cancer ...

High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell lung cancer (NSCLC) ...

Dual Versus Single Checkpoint Inhibition in Advanced Non-Small Cell Lung Cancer: A Pooled Patient-Level Analysis of Six ...

Roche is looking to a busy 2026 after 10 new molecules entered late-stage testing last year and as a potential launch of ...